Faculty of 1000 evaluation for Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.
Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin
Modulation of TNF-induced macrophage polarization by synovial fibroblasts
Tumor necrosis factor α Induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts
TNFα induces sustained signaling and a prolonged and unremitting inflammatory response in synovial fibroblasts
Kinase inhibitors: A new tool for the treatment of rheumatoid arthritis
iRHOM2 is a critical pathogenic mediator of infammatory arthritis
Type i interferons as biomarkers in autoimmune diseases
The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment
Synovial fibroblasts display an uncontrolled inflammatory and tissue destructive response to TNF-α.
Churg-Strauss Syndrome with Eosinophilic Myocarditis: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery
Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages
Overview of the biology of type I interferons
Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling
Indirect Inhibition of Toll-like Receptor and Type I Interferon Responses by ITAM-Coupled Receptors and Integrins
A new tool for detection of type I interferon activation in systemic lupus erythematosus
Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammation.
IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38.
The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
Effect of epoetin alfa therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy
Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease
Capecitabine in pretreated metastatic cholangiocarcinoma. A case report and review of the literature.
Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: Experience from an uncontrolled trial 
Hippocrates and genomic medicine
Pharmacogenetic principles in the Hippocratic writings
Of temples and plane trees: the Hippocratic legacy as collective memory.